Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,071
Closed -$444K 110
2023
Q2
$444K Sell
4,071
-3,815
-48% -$407K ﹤0.01% 511
2023
Q1
$799K Buy
+7,886
New +$833K ﹤0.01% 533
2021
Q2
Sell
-26,122
Closed -$3.13M 533
2021
Q1
$3.13M Buy
26,122
+15,729
+151% +$1.86M 0.02% 226
2020
Q4
$1.14M Sell
10,393
-25,017
-71% -$2.72M 0.01% 356
2020
Q3
$3.85M Buy
35,410
+4,804
+16% +$487K 0.02% 169
2020
Q2
$2.8M Buy
+30,606
New +$2.77M 0.02% 185

Other funds holding ABT

Brookfield Corp's ABT Position: Q3 2023 in Review

Brookfield Corp sold out of Abbott (ABT) in Q3 2023, closing a stake of 4,071 shares — an estimated $444K sold.

Brookfield Corp first reported a position in ABT in Q2 2020 and held it in 6 quarters. The position peaked at $3.85M in Q3 2020. 2,682 funds tracked by Wall St. Rank hold ABT as of Q3 2023.

  • Brookfield Corp reported no remaining Abbott position as of Q3 2023 after selling out during the quarter.
  • Brookfield Corp sold 4,071 Abbott shares in Q3 2023, an estimated $444K.
  • Brookfield Corp first reported a position in Abbott in Q2 2020 and held it in 6 quarters.
  • Brookfield Corp's Abbott position peaked at $3.85M in Q3 2020.
  • 2,682 funds tracked by Wall St. Rank held Abbott as of Q3 2023.

Based on Brookfield Corp's 13F filing for Q3 2023, filed 14 Nov 2023.